Add to ORKGChild mortality remains prevalent in low-income and middle-income countries, with the sub-Saharan Africa region accounting for the largest under-5 mortality rates. Although under-5 mortality rates have significantly decreased, most countries in sub-Saharan Africa with high mortality rates are unlikely to achieve the Sustainable Development Goal of at least as low as 25 deaths per 1000 livebirths by 2030
BackgroundBiannual azithromycin distribution has been shown to reduce child mortality as well as inc...
The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance study showed that adminis...
Recent evidence indicates mass drug administration with azithromycin may reduce child mortality. Thi...
BackgroundWe hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool c...
Mass drug administration (MDA) with azithromycin may reduce under-5 child mortality (U5M) in sub-Sah...
Background: Sub-Saharan Africa remains the region with the highest child mortality rate in the world...
A decade ago, the astonishing and unexpected results of a trachoma trial in Ethiopia1 hinted at the ...
Mass azithromycin distribution has been shown to reduce all-cause mortality in preschool children in...
In this Perspective, David Mabey and colleagues discuss a recent PLOS Medicine article on azithromyc...
BackgroundThe MORDOR I trial (Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance...
Summary: Background: Mass drug administration of azithromycin to children in sub-Saharan Africa has...
BACKGROUND:Biannual, mass azithromycin distribution has previously been shown to reduce all-cause ch...
Background: Mass drug administration (MDA) of azithromycin (AZI) has been shown to reduce under-5 mo...
BACKGROUND: Mass drug administration (MDA) of azithromycin (AZI) has been shown to reduce under-5 mo...
The Sustainable Development Goals (SDG) aim to eliminate preventable child mortality by 2030. Despit...
BackgroundBiannual azithromycin distribution has been shown to reduce child mortality as well as inc...
The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance study showed that adminis...
Recent evidence indicates mass drug administration with azithromycin may reduce child mortality. Thi...
BackgroundWe hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool c...
Mass drug administration (MDA) with azithromycin may reduce under-5 child mortality (U5M) in sub-Sah...
Background: Sub-Saharan Africa remains the region with the highest child mortality rate in the world...
A decade ago, the astonishing and unexpected results of a trachoma trial in Ethiopia1 hinted at the ...
Mass azithromycin distribution has been shown to reduce all-cause mortality in preschool children in...
In this Perspective, David Mabey and colleagues discuss a recent PLOS Medicine article on azithromyc...
BackgroundThe MORDOR I trial (Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance...
Summary: Background: Mass drug administration of azithromycin to children in sub-Saharan Africa has...
BACKGROUND:Biannual, mass azithromycin distribution has previously been shown to reduce all-cause ch...
Background: Mass drug administration (MDA) of azithromycin (AZI) has been shown to reduce under-5 mo...
BACKGROUND: Mass drug administration (MDA) of azithromycin (AZI) has been shown to reduce under-5 mo...
The Sustainable Development Goals (SDG) aim to eliminate preventable child mortality by 2030. Despit...
BackgroundBiannual azithromycin distribution has been shown to reduce child mortality as well as inc...
The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance study showed that adminis...
Recent evidence indicates mass drug administration with azithromycin may reduce child mortality. Thi...